The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially ...

Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all ...

The partnership with Sirius expands CRISPR Therapeutics’ modality toolkit, especially in the cardiovascular space.

Most of the 15 million children with a rare disease have no FDA-approved treatments available to them. And when it comes to ...

The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, ...

The late-stage results come in advance of pivotal data that Ionis expects to provide for its antisense oligonucleotide ...

The agreement comes three months after Pfizer inked a PD-1/VEGF partnership with Summit Therapeutics, leading BMO Capital ...

In an interview on Friday, FDA Commissioner Marty Makary threw his weight behind psychedelic therapies, noting that patients ...